Home > Healthcare > Medical Devices > Therapeutic Devices > Urinary Catheters Market
Urinary Catheters Market size was valued at over USD 5 billion in 2021 and is anticipated to register a CAGR of 4.8% during 2022-2030. The pervasiveness of urinary incontinence will bolster the sales of urinary catheters.
Increasing prevalence of urinary incontinence among the consistently rising geriatric population will spur the market demand. Notably, urinary incontinence, also called overactive bladder is not just prevalent among the elderly but in many older adults as well. The main cause of this condition is bladder injury arising from urinary tract infections.
Report Attribute | Details |
---|---|
Base Year: | 2021 |
Urinary Catheters Market Size in 2021: | 5 billion (USD) |
Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 4.8% |
2030 Value Projection: | 8 billion (USD) |
Historical Data for: | 2017 to 2021 |
No. of Pages: | 330 |
Tables, Charts & Figures: | 623 |
Segments covered: | Product, Device Type, Material, Patient, Application, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Additionally, increasing cases of prostate cancer will transform the urinary catheters market outlook. This type of cancer depicts symptoms like erectile dysfunction, troubled urination, and blood in urine and semen. The rising prostate cancer prevalence is highlighting the importance of timely treatment and bolstering the demand for urinary catheters. Preference among patients for self-catheterization, a rising number of ambulatory surgical centers, and supportive medical reimbursement policies are also estimated to aid the industry expansion.
One of the prevalent nosocomial infections in hospitals or any medical setting is catheter-associated urinary tract infection (CAUTI) – it comprises over 40% of institutionally acquired infections. Urinary catheterization is a complex procedure and needs to be carried out by skilled medical practitioners. Any type of negligence can lead to infections and other complications. The increasing fear of CAUTI and associated health issues along with the availability of alternative treatment options are majorly hampering the market share.